Delivery Order SPE2DX22D0129-SPE2D826F0DCM
- Not listed
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $150,760.44 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,665.95 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The contract is performed out of the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a task order...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $381,227.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded without any set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task...
- On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,262.65 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, represents a child award under a larger indefinite delivery contract vehicle. The contract was competitively awarded with no set-aside designation, and performance will occur at the awardee's Conshohocken,...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,130.75 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 13, 2026 and involves no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $138,741.12 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order executed under AmerSourceBergen's substantial...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $128,662.52 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- On January 9, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,275.80 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price contract, with an ultimate completion date of January 12, 2026, represents a task order issued under a larger indefinite delivery vehicle. The award was made on a competitive, non-set-aside basis. AmerSourceBergen Drug Corp is headquartered in Conshohocken, Pennsylvania, which...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $60,112.64 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 13, 2026. This firm fixed-price delivery order was issued under a competitive, non-set-aside procurement and will be performed at the company's Conshohocken, Pennsylvania facility. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DCMDelivery Order
On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,584.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by January 13, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded and represents a routine procurement transaction within the broader federal pharmaceutical supply chain serving military and veteran healthcare systems. This delivery order operates under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its established capability to meet government procurement requirements through open competition and its critical role as a primary vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 1/11/26 |